4.5 Article

Mitochondrial dysfunction in lung ageing and disease

Journal

EUROPEAN RESPIRATORY REVIEW
Volume 29, Issue 157, Pages -

Publisher

EUROPEAN RESPIRATORY SOC JOURNALS LTD
DOI: 10.1183/16000617.0165-2020

Keywords

-

Funding

  1. US National Institute of Health [R00-HL125899]
  2. Science Foundation Ireland [FRL4862]
  3. Fondation pour la Recherche Medicale [DEQ20170336706]
  4. Agence Nationale pour la Recherche grant ANR, ROSAE project [CE14-0015-01]

Ask authors/readers for more resources

Mitochondrial biology has seen a surge in popularity in the past 5 years, with the emergence of numerous new avenues of exciting mitochondria-related research including immunometabolism, mitochondrial transplantation and mitochondria-microbe biology. Since the early 1960s mitochondrial dysfunction has been observed in cells of the lung in individuals and in experimental models of chronic and acute respiratory diseases. However, it is only in the past decade with the emergence of more sophisticated tools and methodologies that we are beginning to understand how this enigmatic organelle regulates cellular homeostasis and contributes to disease processes in the lung. In this review, we highlight the diverse role of mitochondria in individual lung cell populations and what happens when these essential organelles become dysfunctional with ageing and in acute and chronic lung disease. Although much remains to be uncovered, we also discuss potential targeted therapeutics for mitochondrial dysfunction in the ageing and diseased lung.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available